Wellbeing Digital Subsidiary KGK Science to Participate at the Mushroom Summit
19 Jun 2023 //
BUSINESSWIRE
Wellbeing Subsidiary KGK Science Receives Institutional Review Board Approval
11 Apr 2023 //
BUSINESSWIRE
Wellbeing to Participate at the Cantor Fitzgerald Virtual Panel Discussion
13 Mar 2023 //
BUSINESSWIRE
KGK Science Announces Publication of Safety Studies on Paraxanthine
15 Feb 2023 //
BUSINESSWIRE
Wellbeing Subsidiary KGK Science Announces Successful Results of UP446
06 Dec 2022 //
BUSINESSWIRE
Wellbeing Subsidiary KGK Science Submits CTA for Phase IIA Clinical Trial
30 Nov 2022 //
BUSINESSWIRE
Wellbeing Announces the Appointment of Mohammad Sharifi to Board of Directors
22 Nov 2022 //
BUSINESSWIRE
KGK Science Enters into Research Contract With Nova Mentis for Phase II A Trial
17 Nov 2022 //
BUSINESSWIRE
KGK Science Announces Delivery of CBD and THC Through the Skin of Volunteers
14 Nov 2022 //
BUSINESSWIRE